More flexibility in early-phase development for cell therapies is needed, a panel of US Food and Drug Administration (FDA) ...
This webinar showcases real-world case studies demonstrating how integrated product development strategies can accelerate decision-making, optimize resources and build long-term partnerships in ...
TEL AVIV, Israel, May 17, 2022 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic, fibrosis and ...
Pfizer remains in focus as oncology partnerships, colorectal cancer research developments, and pharmaceutical innovation ...
Zacks Small Cap Research on MSN
AINMF: Company encouraged by rising interest in leveraging AI to improve & derisk clinical trial activity
By M. Marin OTCQB: AINMF READ THE FULL AINMF RESEARCH REPORT AINMF believes platform is well-positioned, as use of AI in clinical development is expected to rise NetraMark (OTCQB: AINMF), an AI ...
Myasthenia Gravis Clinical Trial Pipeline Expands as 25+ Companies Race to Redefine Myasthenia Gravis Treatment Landscape | DelveInsight The myasthenia gravis clinical trial analysis report delivers ...
Bari Kowal, Senior Vice President, Development Operations & Portfolio Management at Regeneron Clinical trial innovation is a hot topic, but it’s not a new one. The first fully virtual randomized trial ...
OXFORD, England--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI) today announced the appointment of two technology and clinical development leaders to senior roles to significantly strengthen the ...
Brings more than 20 years of neurology, clinical development, and translational experience as AstronauTx prepares to advance its lead programmes into clinical developmentAstronauTx also appoints Deb ...
Oral, Selective RBM39 Degrader Under Evaluation in Phase 1 Trial; Preclinical Data Support Expansion Potential Across Ewing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results